Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK ICUs
- PMID: 32609533
- PMCID: PMC7560800
- DOI: 10.1164/rccm.202002-0355OC
Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK ICUs
Abstract
Rationale:Aspergillus infection in patients with suspected ventilator-associated pneumonia remains uncharacterized because of the absence of a disease definition and limited access to sensitive diagnostic tests.Objectives: To estimate the prevalence and outcomes of Aspergillus infection in adults with suspected ventilator-associated pneumonia.Methods: Two prospective UK studies recruited 360 critically ill adults with new or worsening alveolar shadowing on chest X-ray and clinical/hematological parameters supporting suspected ventilator-associated pneumonia. Stored serum and BAL fluid were available from 194 nonneutropenic patients and underwent mycological testing. Patients were categorized as having probable Aspergillus infection using a definition comprising clinical, radiological, and mycological criteria. Mycological criteria included positive histology or microscopy, positive BAL fluid culture, galactomannan optical index of 1 or more in BAL fluid or 0.5 or more in serum.Measurements and Main Results: Of 194 patients evaluated, 24 met the definition of probable Aspergillus infection, giving an estimated prevalence of 12.4% (95% confidence interval, 8.1-17.8). All 24 patients had positive galactomannan in serum (n = 4), BAL fluid (n = 16), or both (n = 4); three patients cultured Aspergillus sp. in BAL fluid. Patients with probable Aspergillus infection had a significantly longer median duration of critical care stay (25.5 vs. 15.5 d, P = 0.02). ICU mortality was numerically higher in this group, although this was not statistically significant (33.3% vs. 22.8%; P = 0.23).Conclusions: The estimated prevalence for probable Aspergillus infection in this geographically dispersed multicenter UK cohort indicates that this condition should be considered when investigating patients with suspected ventilator-associated pneumonia, including patient groups not previously recognized to be at high risk of aspergillosis.
Keywords: Aspergillus; critical care; diagnostic tests; prevalence.
Figures
Comment in
-
Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia: The Hidden Enemy?Am J Respir Crit Care Med. 2020 Oct 15;202(8):1071-1073. doi: 10.1164/rccm.202006-2605ED. Am J Respir Crit Care Med. 2020. PMID: 32730104 Free PMC article. No abstract available.
-
Aspergillosis in the ICU: Hidden Enemy or Bogeyman?Am J Respir Crit Care Med. 2021 Apr 15;203(8):1043-1044. doi: 10.1164/rccm.202012-4486LE. Am J Respir Crit Care Med. 2021. PMID: 33497586 Free PMC article. No abstract available.
-
Reply to Aberegg and Wolfe: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?Am J Respir Crit Care Med. 2021 Apr 15;203(8):1044-1045. doi: 10.1164/rccm.202101-0026LE. Am J Respir Crit Care Med. 2021. PMID: 33497595 Free PMC article. No abstract available.
References
-
- Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170:621–625. - PubMed
-
- Pegorie M, Denning DW, Welfare W. Estimating the burden of invasive and serious fungal disease in the United Kingdom. J Infect. 2017;74:60–71. - PubMed
-
- Dorgan E, Denning DW, McMullan R. Burden of fungal disease in Ireland. J Med Microbiol. 2015;64:423–426. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
